Charles Roberts, Cancer Center Director and Executive Vice – President at St. Jude Children’s Research Hospital, shared American Association for Cancer Research’s post on LinkedIn, adding:
“It was a privilege to join Patrick Tan and Atsushi Kaneda for this plenary discussion on navigating genomic and epigenomic complexity in rare cancers.
Every type of pediatric cancer is rare compared to adult cancers. Moreover, 55% of gene mutations that drive pediatric cancer are not found in adult cancers.
As we move from an era of treating cancer with broadly toxic chemotherapy towards an era of more targeted therapies, it will no longer be the case that new therapies can ‘trickle down’ from adult trials to children because most of the childhood cancer mutations are different. Therefore, dedicated efforts are needed to identify actionable therapeutic targets in the genomes and epigenomes of pediatric cancers.
Thank you to American Association for Cancer Research for enabling important conversations to shape the future of rare cancer research, and for keeping children with cancer in mind.”
Quoting American Association for Cancer Research’s post:
“Patrick Tan, Charles Roberts, and Atsushi Kaneda discussed ‘Navigating Genomic and Epigenomic Complexity in Rare Cancers’ during a plenary session at the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers.”
Other articles featuring Charles Roberts on OncoDaily.